Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Cancers|December 28, 2019
Structure and Optimization of Checkpoint InhibitorsSarah L Picardo, Jeffrey Doi, Aaron R HansenBritish Journal of Clinical Pharmacology|May 13, 2020
Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?Geoffrey Alan Watson, Jeffrey Doi, Aaron Richard Hansen, et al.Current Oncology (Toronto, Ont.)|January 27, 2021
Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the LiteratureLawrence Kasherman, Jeffrey Doi, Katherine Karakasis, et al.Targeted Oncology|May 31, 2022
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket StudyAbdulazeez Salawu, Aaron R Hansen, Anna Spreafico, et al.The Oncologist|May 22, 2026
CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National CompetitivenessAshley A Adile, Gagan Sran, Philippe Bedard, et al.Pageof 1